<DOC>
	<DOCNO>NCT02496975</DOCNO>
	<brief_summary>This prospective , randomize , placebo-controlled study Cyclosporine A ( CSP ) traumatic brain injury ( TBI ) . Cyclosporine A drug already market available disease , approve Food Drug Administration treatment traumatic brain injury . The effect Cyclosporine A chemical produce follow brain injury determine use dos large used patient organ transplant . It also give much short time period ( 3 day ) . It know side effect see patient take cyclosporine A occur give 3 day . It known patient brain injury treat cyclosporine A side effect like see organ transplant patient .</brief_summary>
	<brief_title>Traumatic Brain Injury Effects Acute Cyclosporine A</brief_title>
	<detailed_description>The purpose research study measure chemical produce brain injured also Cyclosporine A treatment change chemical . By study , investigator hope learn cyclosporine A therapy help patient injury . The research procedures happen University Kentucky ( UK ) Chandler Medical Center . The study last first 7 day participant admit UK Medical Center , release . Participants ask stay longer hospital research study . Participants study receive therapy currently available treatment severe brain injury . Each participant assign randomly ( chance ) either placebo ( substance without active drug ) cyclosporine A treatment . Neither participant study personnel know study treatment assign participant . If assign cyclosporine A treatment group ( study drug ) participants continuously administer study drug tube place vein . A placebo give participant assign placebo group . Blood cerebrospinal fluid collect following time point ( 12 , 24 , 36 , 48 , 60 72 hour ) research purpose . These test help u understand participant 's ability make red white blood cell fight infection , well kidneys function , well liver function , triglyceride/cholesterol level . Cerebrospinal fluid collect participant drain catheter place part routine care . Daily blood collection occur investigator measure much study drug present , ass body chemical brain also safety . Blood sample collect use already place line vein artery , puncture skin needle . The chemical measure daily urine also fluid drain line place head medical management 7 day . Any unexpected event ( side effect ) possibly cause cyclosporine A note medically manage physician . The investigator notify need intervention . After three day continuous dosing , study drug stop , participant continue carefully monitor 7 day , release . Participants receive usual treatment severe traumatic brain injury addition receive cyclosporine A treatment placebo .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Participant age 18 65 Participant speaks understand English CT Scan evidence severe TBI Post resuscitation GSC 48 least one reactive pupil motor score great 5 Study medication administer within 8 hour injury Participant receive high dose systemic corticosteroid , Methylprednisolone &gt; 15 mg/kg equivalent , Participant know allergy cyclosporine A , Participant pregnant , Participant le 18 year age great 65 year Participant history kidney problem , history stroke spinal cord injury , Participant history cardiovascular disease , use immunosuppressive therapy last three month , Participant history malignant tumor unless remission least five year . Participant active infection Participant take part another investigational trial within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>